Released into the vasculature from disrupted cells or transported to the su
rface of adjacent effecters, phosphatidate and related lipids may potentiat
e endothelial cell activation. However, the effect of these lipids on endot
helial monolayer barrier integrity has not been reported. The present study
documents the induction of endothelial monolayer permeability by phosphati
date. Both long (di-C18:1) and medium (di-C10; di-C8) chain length phosphat
idates increased permeability of bovine pulmonary artery endothelial cell m
onolayers assessed using a well characterized assay system in vitro. Barrie
r disruption effected by dioctanoyl (di-C8) phosphatidate was markedly pote
ntiated by the addition of propranolol, an inhibitor of endothelial cell "e
cto"-phosphatidate phosphohydrolase (PAP), a lipid phosphate phosphohydrola
se (LPP) that efficiently hydrolyzes extracellular substrate. Disruption of
barrier function by phosphatidate did not result from its non-specific det
ergent characteristics, since a non-hydrolyzable but biologically inactive
phosphonate analog of dioctanoyl phosphatidate, which retains the detergent
characteristics of phosphatidate, did not induce permeability changes. Fur
thermore, neither diacylglycerol nor lyse-PA effected significant increases
in monolayer permeability, indicating the observed response was due to pho
sphatidate rather than one of its metabolites. Phosphatidate-induced permea
bility was attenuated by preincubation of endothelial cells with the tyrosi
ne kinase inhibitor, herbimycin A(10 mu g/ml), and enhanced by the tyrosine
phosphatase inhibitor, vanadate (100 mu M), implicating a role for activat
ion of intracellular tyrosine kinases in the response. In addition, phospha
tidate increased the levels of intracellular free Ca2+ in endothelial cells
and ligated specific binding sites on endothelial cell plasma membranes, c
onsistent with the presence of a phosphatidate receptor. Since phosphatidat
e generated within the plasma membrane of adherent effecters potentially in
teracts with endothelial membranes, we evaluated the influence of phosphati
date-enriched neutrophil plasma membranes on endothelial monolayer integrit
y. The effects of ectopic phosphatidate on endothelial monolayer permeabili
ty were mimicked by phosphatidate confined to neutrophil plasma membranes.
We conclude that phosphatidate may be a physiologic modulator of endothelia
l monolayer permeability that exerts its effects by activating a receptor-l
inked, tyrosine kinase-dependent process which results in mobilization of i
ntracellular stored Ca2+ and consequent metabolic activation. (C) 1999 Wile
y-Liss, Inc.